Stock SNOA SONOMA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Sonoma Pharmaceuticals, Inc.

Equities

SNOA

US83558L2043

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
0.1899 USD +0.05% Intraday chart for Sonoma Pharmaceuticals, Inc. -1.09% +5.27%
17/06 Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
09/05 Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results
AQ
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
CI
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
AQ
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
AQ
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
AQ
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
AQ
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-The-Counter Skincare Product for Daily Use
CI
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union through Sonoma's Extensive Distributor Network
AQ
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma?s Extensive Distributor Network
CI
Sonoma Pharmaceuticals : Material Agreement - Form 8-K
PU
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Sonoma Pharmaceuticals, Inc. Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation At the Symposium on Advanced Wound Care Fall Conference
CI
Sector Update: Health Care Stocks Ease in Late Afternoon
MT
Sector Update: Health Care
MT
Top MIdday Decliners
MT
Wall Street Set to Open Lower as GDP, Jobless Claims Higher Than Expected
MT
Sonoma Pharmaceuticals : Investor Presentation October 2023 - Form 8-K
PU
Ladenburg Thalmann Initiates Coverage on Sonoma Pharmaceuticals at Buy, $3.25 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNOA Stock
  4. News Sonoma Pharmaceuticals, Inc.